Author avatar

Centeno, Jose A.  PhD

Leading researcher with 163 publications
Jose A. Centeno, MSc, PhD, FRSC 1. Adjunct Professor, Department of Chemistry, University of Puerto Rico at Mayaguez, 2. Adjunct Professor of Medicine, University of Maryland School of Medicine, Division of Occupational and Environmental Medicine 3. Professor of Chemistry (Professor Titular), Faculty of Chemistry, Universidad de la Republica de Uruguay, Montevideo, Uruguay 4. Fellow Royal Society of Chemistry, FRSC, London, UK 5. Honorary Academician, Royal Academy of Medicine and Surgery, Andalucia Oriental, Spain 6. Founder and Director, International Environmental & Health Sciences Consortium (www.iehsconsortium.org) Dr. Jose A. Centeno is a Physical Chemist (Toxicologist) by training, with international and nationally recognized expertise in biophysical toxicology, bioanalytical chemistry, environmental and toxicologic pathology, nanotechnology, medical devices, regulatory science and medical geology. He is graduate from the University of Puerto Rico at Mayaguez (BS (Chemistry) and MS (Physical Chemistry), a Ph.D. in Physical Chemistry from Michigan State University and completed a postdoctoral fellowship training in biophysics and chemical pathology at the U.S. Armed Forces Institute of Pathology. Dr. Centeno has served the US Federal Government in several scientific and senior managerial appointments. Most recently, he served as the Director of the Division of Biology, Chemistry and Materials Science (DBCMS) within the Office of Sciences and Engineering Laboratories (OSEL), Center for Devices and Radiological Health (CDRH), US Food and Drug Administration (USFDA), from June 2015 to December 2019. As DBCMS Director, he had the responsibility of managing and lead a scientific team composed of over 30 senior level government scientists, postdoctoral fellows, students and visiting scientists, as well as overseen all the Division operational activities, budget allocations and laboratory research activities which included research programs in the areas of biocompatibility and toxicology, microbiology and infection control, materials science, and nanotechnology. He served as director of the CDRH-OSEL Advanced Characte-rization Facility and managed the research and training activities in nanotechnology. As DBCMS Director, Dr. Centeno managed a regulatory research portfolio with over 40 projects aimed at ensuring the safety and efficacy of medical devices. DBCMS research program contributes to regulatory decision-making in CDRH and directly impacts the development of CDRH guidance documents and international standards in the areas of biocompatibility, toxicological risk assessment, and nanotechnology. During his tenure at the FDA, Dr. Centeno represented the Agency in a wide range of national and international regulatory and scientific committees including serving as FDA Primary Liaison to the International Standard Organization Technical Committee on Nano-technology (ISO TC 229 Nanotechnologies), Chair of the US Technical Advisory Committee (US TAG ISO TC 229 Nanotechnologies) Working Group 5 on “Performance and Applications”, CDRH Delegate to the US Pharmacopeial Convention (USP), and member of the Interagency Working Group on Asbestos in Consumer Products (IWGACP). Prior to joining the USFDA, Dr. Centeno worked for the U.S. Department of Defense (DoD) for over 25-years, serving as a senior research scientist and Director, Bioinorganic and Metal Toxicology Laboratory for the Armed Forces Institute of Pathology (AFIP). During his tenure with the AFIP/US-DoD, Dr. Centeno worked in developing research and diagnostic areas such as environmental pathology, forensic toxicology analysis, trace element speciation analysis and exposure assessment to toxic metals of military and public health relevance, and applications of bio-spectroscopy studies to better under-stand foreign body reaction to bio-implantable materials. He established several registries for the study of diseases associated with exposure to chemical, environment show More

Preview

Evolution over the last 10 years of activity
Aggregated career metrics
163

Total documents

1.2

Normalized Impact

18

Highly Cited Papers (10%)

18.4

International Collab. (%)

Most cited publications


Main coauthors


Following you can review Jose A.'s accomplishments in each of the dimensions.

The perfect present for a young Researcher!

Let's do it!
Gift

Dimensions One by One

Spanning 73 diverse indicators, the dimensions considered capture a comprehensive spectrum of academic attributes. Each dimension includes a set of indicators and has a especific weight on the One Index. More information here...

Activity

0
/1000
Reflects an author's research output.

Impact

0
/1000
Reflects an author's academic visibility and the exceptional quality and influence of their most highly cited works.

Excellence

0
/1000
Reflects an author's academic visibility and the exceptional quality and influence of their most highly cited works.

Leadership

0
/1000
Reflects an author's efforts and commitment in leading research initiatives.

Cooperation

0
/1000
Reflects a researcher's ability to navigate and thrive in varied academic and research environments, highlighting adaptability, resourcefulness, and the capacity to build and maintain collaborative relationships across the spectrum of their career.

Openness

0
/1000
Reflects an author's commitment to making their research freely accessible and open to the public.

Community Support

0
/1000
Reflects an author's contributions to the academic community beyond their own research.

Community Recognition

0
/1000
Reflects the academic community's acknowledgment and appreciation of an author's contributions.

Transference

0
/1000
Reflects an author's commitment to making their research a practical application and real-world impact of an author's research.

Fundraising

0
/1000
Reflects an author's ability in securing project funding from major global entities, showcasing your ability to drive research initiatives forward.